As of Dec 02
| -0.58 / -1.73%|
The 20 analysts offering 12-month price forecasts for Novozymes A/S have a median target of 36.40, with a high estimate of 55.39 and a low estimate of 32.29. The median estimate represents a +10.41% increase from the last price of 32.97.
The current consensus among 20 polled investment analysts is to Hold stock in Novozymes A/S. This rating has held steady since November, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.